Robert M. Plenge - EVP, Chief Research Officer at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Research Officer
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert M. Plenge since 12/17/2023

Holdings reported by Robert M. Plenge for Bristol Myers Squibb Co

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Market Share Units 15.5K $833K $53.79 Mar 10, 2024 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 11.3K $609K $53.79 Mar 10, 2024 Direct
Common Stock, $0.10 par value 1.66K $89.1K $53.79 Mar 10, 2024 BMS Savings and Investment Program
Common Stock, $0.10 par value 200 $10.8K $53.79 Mar 10, 2024 Family Trust
Performance Shares 23.2K Mar 10, 2024 Direct Common Stock, $0.10 par value
Restricted Stock Units 0 $50.10 Dec 2, 2023 Direct Common Stock, $0.10 par value

Transactions reported by Robert M. Plenge for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.